No references yet — be the first to submit one

Kiniksa Pharmaceuticals International, Plc is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company specializes in developing treatments for autoinflammatory and autoimmune conditions, with a particular emphasis on rare diseases and conditions involving dysregulated immune responses. Kiniksa's pipeline includes both small molecule and biologic therapies targeting various inflammatory pathways and immune system disorders.